| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 18,671 | 7,729* | NaN | NaN |
| Cost of sales - product | 2,772 | 1,150* | NaN | NaN |
| Cost of sales - intangible amortization | 279 | 175* | NaN | NaN |
| Research and development | 38,218 | 28,650* | NaN | NaN |
| Revenue-Product | NaN | NaN | 11,242 | NaN |
| Selling, general and administrative | 22,299 | 20,287* | NaN | NaN |
| Cost of sales - product | NaN | NaN | 1,670 | NaN |
| Total operating expenses | 63,568 | 50,261* | NaN | NaN |
| Cost of sales - intangible amortization | NaN | NaN | 290 | NaN |
| Loss from operations | -44,897 | -42,532* | NaN | NaN |
| Research and development expenses | NaN | NaN | 28,412 | NaN |
| Other expense | -61 | -51* | NaN | NaN |
| Commercial expenses | NaN | NaN | 9,594 | NaN |
| Interest income | 1,297 | 1,017* | NaN | NaN |
| Medical affairs expenses | NaN | NaN | 3,047 | NaN |
| General and administrative expenses | NaN | NaN | 6,764 | NaN |
| Stock-based compensation expense | NaN | NaN | 2,178 | NaN |
| Depreciation expense | NaN | NaN | 2 | NaN |
| Interest income | NaN | NaN | 1,182 | NaN |
| Interest expense | 382 | 342* | 319 | NaN |
| Loss on debt extinguishment | NaN | -456* | NaN | NaN |
| Change in fair value of warrant liability | -9,323 | -24,078* | 55,881 | NaN |
| Change in fair value of notes | 1,871 | 4,507* | 2,748 | NaN |
| Other segment items | NaN | NaN | 37 | NaN |
| Net loss before taxes | NaN | -22,793 | NaN | NaN |
| Net loss | -36,591 | -22,793* | -98,518 | -25,934 |
| Unrealized gain (loss) on available-for-sale securities | -7 | NaN | NaN | NaN |
| Change in fair value of notes attributable to instrument specific credit risk | -3,396 | 912* | -2,745 | -1,349 |
| Comprehensive loss | -33,202 | -23,705 | -95,773 | -24,585 |
| Basic EPS | -0.37 | -0.345 | -1.35 | -0.39 |
| Diluted EPS | -0.46 | -0.39 | -1.35 | -0.62 |
| Basic Average Shares | 98,292,000 | 68,627,000 | 73,157,000 | 66,143,000 |
| Diluted Average Shares | 99,148,000 | 60,733,000 | 73,157,000 | 74,037,000 |
Verastem, Inc. (VSTM)
Verastem, Inc. (VSTM)